100 related articles for article (PubMed ID: 15663722)
1. Heterogeneity of platelet responsiveness to anti-CD36 in plasma associated with adverse transfusion reactions.
Wakamoto S; Fujihara M; Urushibara N; Morishita K; Kaneko S; Yasuda H; Takayama H; Yamamoto S; Azuma H; Ikeda H
Vox Sang; 2005 Jan; 88(1):41-51. PubMed ID: 15663722
[TBL] [Abstract][Full Text] [Related]
2. Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies.
Bachelot C; Saffroy R; Gandrille S; Aiach M; Rendu F
Thromb Haemost; 1995 Dec; 74(6):1557-63. PubMed ID: 8772237
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of platelet aggregation induced by HLA-related antibodies.
Brandt JT; Julius CJ; Osborne JM; Anderson CL
Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
[TBL] [Abstract][Full Text] [Related]
4. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
Brandt JT; Isenhart CE; Osborne JM; Ahmed A; Anderson CL
Thromb Haemost; 1995 Dec; 74(6):1564-72. PubMed ID: 8772238
[TBL] [Abstract][Full Text] [Related]
5. CD36 immunization in a patient undergoing hematopoietic stem cell transplantation.
Culler EE; Hillyer CD; Haight AE; Castillejo MI; Josephson CD
Pediatr Blood Cancer; 2008 Mar; 50(3):660-2. PubMed ID: 17330834
[TBL] [Abstract][Full Text] [Related]
6. Human platelet activating antibodies.
Christie DJ; Swinehart CD
Semin Thromb Hemost; 1992; 18(2):186-92. PubMed ID: 1631566
[TBL] [Abstract][Full Text] [Related]
7. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody.
Morishita K; Wakamoto S; Miyazaki T; Sato S; Fujihara M; Kaneko S; Yasuda H; Yamamoto S; Azuma H; Kato T; Ikeda H
Transfusion; 2005 May; 45(5):803-6. PubMed ID: 15847672
[TBL] [Abstract][Full Text] [Related]
8. Human platelet antigen-1a antibodies induce the release of the chemokine RANTES from human platelets.
Dettke M; Dreer M; Höcker P; Panzer S
Vox Sang; 2001 Oct; 81(3):199-203. PubMed ID: 11703865
[TBL] [Abstract][Full Text] [Related]
9. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
[TBL] [Abstract][Full Text] [Related]
10. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.
Ockenhouse CF; Magowan C; Chulay JD
J Clin Invest; 1989 Aug; 84(2):468-75. PubMed ID: 2474569
[TBL] [Abstract][Full Text] [Related]
11. A structural/functional domain on human CD36 is involved in the binding of anti-Nak(a) antibodies.
Daviet L; Morel-Kopp MC; Kaplan C; McGregor JL
Thromb Haemost; 1995 Mar; 73(3):543-5. PubMed ID: 7545324
[TBL] [Abstract][Full Text] [Related]
12. Humanized mouse models of FcR clearance in immune platelet disorders.
McKenzie SE
Blood Rev; 2002 Mar; 16(1):3-5. PubMed ID: 11913983
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against human cell receptors, CD36, CD41a, and CD62P crossreact with porcine platelets.
Delgado AV; Alexander SL; McManus AT; Pusateri AE
Cytometry B Clin Cytom; 2003 Nov; 56(1):62-7. PubMed ID: 14582138
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury.
Nishimura M; Takanashi M; Okazaki H; Satake M
Cell Biochem Funct; 2007; 25(2):179-83. PubMed ID: 16287215
[TBL] [Abstract][Full Text] [Related]
15. Refractory platelet transfusion in a patient with CD36 deficiency due to pseudothrombocytopenia.
Yin XL; Shen WD; Chen YS; Zhou Y; Zhang XH
Platelets; 2011; 22(3):237-40. PubMed ID: 21143025
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
[TBL] [Abstract][Full Text] [Related]
17. Two cases of platelet transfusion refractoriness associated with anti-CD36.
Saw CL; Szykoluk H; Curtis BR; Zelcer S; Eckert K; Forrest D; Nickerson P; Petraszko T; Goldman M
Transfusion; 2010 Dec; 50(12):2638-42. PubMed ID: 20561295
[TBL] [Abstract][Full Text] [Related]
18. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.
Nagarajan S
Immunol Lett; 2007 Jan; 108(1):52-61. PubMed ID: 17081622
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.
Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940
[TBL] [Abstract][Full Text] [Related]
20. Activation of human platelets by misfolded proteins.
Herczenik E; Bouma B; Korporaal SJ; Strangi R; Zeng Q; Gros P; Van Eck M; Van Berkel TJ; Gebbink MF; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1657-65. PubMed ID: 17510465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
